
Nabeel Aslam
Nephrology · Mayo Clinic Jacksonville
Credentials: · · ·
History

1996–1999- 1993–1996
House Officer Mayo Hospital
Research
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
New England Journal of Medicine · 2019 · 496 citations
Clinical Journal of the American Society of Nephrology · 2006 · First of 5 authors · 110 citations
Large body mass index does not predict short-term survival in peritoneal dialysis patients
Peritoneal Dialysis International · 2002 · First of 4 authors · Corresponding · 70 citations

7 papers
- CC
6 papers

6 papers · 2 as a fellow
- BP
5 papers

5 papers · 1 as a fellow

5 papers

5 papers

4 papers
Clinical trials
- 2025–2029
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
Principal investigator · Recruiting · Phase 2
Mayo Clinic
- 2022–2028
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
- 2020–2030
Belimumab With Rituximab for Primary Membranous Nephropathy
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)


